India, Feb. 7 -- As per Pharmarack's PHARMATRAC MAT December 2025, the Nutritionals segment reached Rs 21,288 crore, registering 6 per cent value growth

The Indian Nutritionals market is entering a phase of consolidation after the COVID-led surge of FY21-22, with December 2025 data highlighting a clear shift in growth drivers and consumption patterns. As per Pharmarack's PHARMATRAC MAT December 2025, the nutritionals segment reached Rs 21,288 crore, registering 6 per cent value growth, largely supported by 6 per cent price growth despite a 3 per cent decline in volumes, indicating premiumisation and evolving consumer preferences. Demand is increasingly moving away from traditional prescription-led vitamins toward OTC, nutraceutical, and ...